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Abstract

Introduction

It is generally recognized that calcium oxalate
crystal formation in urine is induced by heterogeneous
nucleation. However, there is no consensus as to the
nature of the nucleation substrate. Evidence is provided
in this paper that membranous cellular degradation products are the most likely candidates because they: (1) are
ubiquitous in urine and urinary stones; (2) are found in
close association with crystal deposits in the kidneys;
and (3) can induce nucleation of crystals from a metastable solution of calcium oxalate in vitro and metastable
urine in vivo.

An important event in the onset of urolithiasis is
supersaturation of urine with a potentially precipitating
crystalline phase; the greater the supersaturation, the
greater the likelihood of precipitation [31]. Supersaturated urine can be metastable or unstable. In an unstable
solution, crystals form spontaneously by homogeneous
nucleation. In a metastable solution, crystals may be induced by a foreign interface such as certain macromolecules or other crystals that can act as nidi for crystal
nucleation. Extremely high levels of supersaturation are
necessary to produce homogeneous nucleation and it is
highly unlikely that the spontaneous formation products
of any of the stone salts will ever be attained in the
urine. For example, homogeneous nucleation of calcium
oxalate (CaOx) monohydrate does not dominate until
relative supersaturation reaches 70 and CaOx relative
supersaturation in mammalian urine rarely exceeds 30
[19, 30, 31]. Moreover, since urine contains a number
of macromolecules and cellular degradation products, it
is most likely that the nucleation therein is heterogeneous. This thinking was reflected in the report of the
1981 Dahlem Conference on Biological Mineralization
and Demineralization [78] which concluded that (1)
"homogeneous nucleation of any of the urinary stone
salts or acids is unlikely", and (2) "nucleation of urinary calculi is probably heterogeneous". United States
National Institutes of Health Consensus Development
Conference on Prevention and Treatment of Kidney
Stones, held in March 1988 [79], also concluded that
"disorders that raise supersaturation and promote
heterogeneous nucleation are the presently accepted
causes of nephrolithiasis".

Key Words: Calcium oxalate, nephrolithiasis, cell
membrane, urolithiasis, matrix vesicles, mineralization,
calcium phosphate.

Crystals as Nucleators

What are the substrates acting as heterogeneous nucleators? Are they crystalline or macromolecular? Is
there a specific substrate for a specific crystal type, or
is heterogeneous nucleation simply a result of the presence of a foreign interface? Based upon the observa-
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tions that calcium phosphate (CaP) is the most common
crystal in human urine [117), is ubiquitous in human urinary stones, and is often seen at the center of the mixed
CaOx/CaP urinary stones [84), nucleation of CaOx crystals is proposed to be induced by CaP crystals. In addition, both apatite and brushite crystals have been shown
to induce crystallization of CaOx in vitro from a metastable solution of CaOx [76, 85). On the other hand,
solubility of CaP is very sensitive to pH: it decreases
with increasing pH [30, 90). Generally the apatite
forms at higher, more alkaline pH, while brushite, at
lower, more acidic pH. Even though brushite is not a
common constituent of CaOx stones, suggestions have
been made that brushite nucleates CaOx crystals and
then transforms into apatite [30, 85). Most idiopathic
CaOx stone formers neither have a highly alkaline nor
acidic urine. In practice, lowering the urinary pH of
CaOx stone formers by simple acidification did not replace apatite with brushite but resulted in the formation
of purer CaOx stones [30, 90).
Octacalcium phosphate, another crystal rarely encountered in kidney stones, has also been suggested to
play a role in initiation of renal calculi. Recently
Achilles et al. [1] grew spherulitic CaP in a gel matrix
at 37°C from a supersaturated metastable solution continuously flowing over the gel surface. The spherulites
contained a poorly crystalline core of amorphous carbonate apatite surrounded by a well crystallized shell of radially oriented sheets of octacalcium phosphate. Subsequently CaOx monohydrate crystals were grown on these
spherulites by continuously flowing a solution supersaturated with respect to CaOx. Plate-like crystals of CaOx
monohydrate demonstrated oriented growth in continuation with the plate-like crystals of octacalcium phosphate
indicating epitaxially mediated crystal nucleation.
It has been demonstrated that even though excreted
urine is generally supersaturated with respect to CaOx
and CaP, the two crystallize and deposit at different locations in the kidneys [49, 55]. Calcium oxalate crystals
generally deposit in collecting ducts of the renal papilla
while calcium phosphate deposits in earlier segments of
the nephron at the cortico-medullary junction. Data
have been presented to support the hypothesis that urine
becomes supersaturated with respect to calcium phosphate as early as the loop of Henle [21). In a recent
study [73), crystallization was induced by standardized
increments of calcium and oxalate in solutions with a
composition corresponding to various segments of the
nephron. Crystals of CaP were predominantly formed
in solutions with composition corresponding to the urine
in proximal tubules while CaOx crystals were formed in
solutions with composition corresponding to the urine in
the collecting ducts. Moreover, sex hormones appear to
play an important role in nephrolithiasis. Kidneys of

male rats are prone to form calcium oxalate deposits
while kidneys of female rats tend to form calcium phosphate [49). Sex hormone dependence of crystallization
may be one reason why CaOx nephrolithiasis is more
common in men while CaP nephrolithiasis is more common in women [84). Urine spends only a few minutes
in the renal tubules, which is not enough time for single
crystals of CaOx to grow large enough for their retention within the renal tubules [32). The formation of a
nucleating CaP crystals, and then nucleation and growth
of CaOx crystals, should take even longer making it
more difficult for CaOx crystals to reach a size large
enough for retention and development of a kidney stone.
Recent studies have demonstrated that urinary crystals of calcium-containing salts almost always have a
macromolecular coating. Transmission electron microscopic examination of urinary stones as well as other
mineralized tissues has shown that demineralization results in replacement of crystals by crystal ghosts which
represent the macromolecular coat [53, 54]. Thus, in
the urinary environment, actual crystal surfaces may not
be available for heterogeneous nucleation. CaP crystals
in the renal fluid may not necessarily induce nucleation
of CaOx in the kidneys just because CaP can act as heterogeneous nucleator of CaOx in vitro. If urinary crystals do play a role in nucleation of other crystals, they
most probably are involved through the adsorbed macromolecules. Macromolecules dissolved in solution often
act as inhibitors of crystallization, but once adsorbed on
a surface, they may promote crystallization [18).
What about the presence of CaP crystals in CaOx
stones, particularly the stone center? These CaP crystals
may be adventitiously acquired by the CaOx stones and
may simply represent crystalluria particles formed during alkaline tides [90). Stone nidus may be formed by
aggregation and retention of crystals [53] which later become covered with a mantle of organic matrix material.
Such a surface could provide a platform for further crystal deposition similar to foreign body encrustation [52).
Similarly, Randall's plaques, which are papillary calcifications, rich in organic material [92), might also act as
encrustation platforms and become nidi for the formation
of renal stones. Thus, a kidney stone with CaP in the
center may originate with intratubular precipitation and
retention of CaP crystals which become overgrown with
CaOx monohydrate [46).
In some in vitro studies, crystals of uric acid [39)
and sodium acid urate [22, 86) have been shown to be
able to induce heterogeneous nucleation of CaOx. Other
studies, however, showed that uric acid crystals were
not good nucleators of CaOx, and sodium acid urate
crystals, though good nucleators, are generally not precipitated in the urine [33). On the other hand, evidence
has been presented that dissolved urate, at normal
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promotive role of the urinary protein; actually, they
have found the THP/uromucoids to be inhibitors of
CaOx and uric acid crystallization [28, 36, 70, 99].
Most of the current research on role of THP in nephrolithiasis indicates that the significance of THP lies in its
involvement in CaOx crystal aggregation and depends on
THP viscosity and solubility [40, 41]. At low ionic
strength and high pH, THP is a powerful crystal aggregation inhibitor. Decreasing pH and increasing ionic
strength, increase THP viscosity and its crystal aggregation inhibition potential [41]. High calcium lowers THP
solubility and promotes crystal aggregation, while high
citrate has the opposite effect. THP from severely recurrent CaOx stone patients appears abnormal. It demonstrates increased polymerization and reduced solubility, and thus, less potential for inhibiting CaOx crystal
aggregation. As with matrix substance A mentioned earlier, the questions about Tamm-Horsfall's role in crystallization are also not yet resolved.
Many other macromolecules, having high affinity
for calcium, have also been isolated from both urine and
urinary stone matrix [94] and it has been shown that the
urines of active CaOx stone formers have greater calcium binding capacity than those of non-stone formers or
inactive stone formers [93]. A protein containing the
calcium binding amino acid, gamma-carboxyglutamic
acid, has been isolated from the urine of stone formers
and matrix of calcium containing urinary stones [72]. It
has been suggested that this protein may provide a substrate for nucleation of calcium-containing crystals. In
a similar vein, Pinto et al. [88] isolated a urinary protein
from the urine of stone formers that binds calcium and
phosphate and promotes CaOx precipitation. Resnick
and associates [93, 110] demonstrated the presence of
uronic acid containing calcium-binding macromolecules
in the urine of non-infectious CaOx stone formers and
postulated a role for such molecules in crystal nucleation. In an experimental model, Itatani et al. [45] induced calcium containing stones by unilateral obstruction
of ureters of rabbits, which normally have massive calcite crystalluria without stone formation. They found
increased uronic acid production by the stone forming
kidneys and concluded that calcium binding sulfated acid
glycosaminoglycans produced by the kidneys resulted in
crystal aggregation and the development of stones. In a
similar study, using the same rabbit model, Wakatsuki
et al. [115], however, found an increase in non-acidic
non-sulfated glycosaminoglycan, hyaluronate, in the
stone forming kidneys. Moreover, urinary glycosaminoglycans, particularly those precipitable with Alcian blue,
are also considered powerful inhibitors of crystallization
[100].
Some of the other urinary macromolecules involved
in CaOx nephrolithiasis: nephrocalcin [77], uropontin

physiological pH, can directly provoke CaOx crystal
nucleation by the phenomenon of salting out [37, 98].
Growth of CaOx monohydrate on uric acid crystals may
also be epitaxially mediated since CaOx monohydrate
crystals grow on uric acid seeds in preferred orientation
and CaOx monohydrate and uric acid form good atomic
matches at the crystal surface [74].

Urinary Macromolecules as Nucleators
Since all urinary stones contain an organic matrix
which is intimately associated with the crystals and consists essentially of the same proteins as the urine, it has
long been suggested that urinary proteins are precursors
of stone matrix and promoters of crystallization [13].
This subject has been recently discussed in an excellent
review by Ryall and Stapleton [97]. Therefore, only the
very pertinent elements will be addressed here.
Early studies suggested that the most prominent antigenic content of stone matrix called matrix substance A,
accounted for up to 85 % of its proteins [118]. It was
reported to be present in the urine of stone patients, to
originate from the renal parenchyma, and to be absent
from the urine or the kidneys of normal individuals.
This protein was suggested to be essential for the formation of urinary stones. However, the hypothesis that
matrix substance A is involved in stone formation is
weakened by the observations that this substance is present in the urine of a variety of patients with renal injury
[47], particularly those with infection of the urinary tract
and is further undermined by results of later studies that
showed that matrix substance A containing fraction of
the stone matrix actually inhibited the growth of CaOx
crystals in vitro [34].
Tamm-Horsfall protein/uromucoid complex, present
both in urinary stone matrix and urine [118], is another
substance suggested to be a promoter of crystallization
of CaP as well as CaOx by providing nidi for their heterogeneous nucleation. Boyce et al. [15] studied in vitro
crystallization of CaP in the presence of uromucoid derived from normal urine and showed the amount of precipitate formed to be proportional to the concentration of
uromucoid. In recent years, Rose and Sulaiman [95, 96]
studied the role of Tamm-Horsfall protein (THP) and
uromucoids on the crystallization of CaP and CaOx and
showed that polymerized and aggregated Tamm-Horsfall
protein acts as a promotor. For their studies, they rapidly evaporated crystal-free urine at 37°C on a rotary
evaporator to 1250 mosmol/kg and found that the removal of macromolecules from the urine by ultrafiltration reduced the amount of precipitate formed and that
this reduction was largely abolished by addition of physiological quantities of Tamm-Horsfall protein. A number
of workers in the field have been unable to confirm the
599
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(osteopontin) [42, 102), uronic acid rich protein [4, 5),
inter-alpha trypsin inhibitor [ 107), and urinary prothrombin fragment 1 (crystal matrix protein) [23, 108, 109)
have all been shown to be inhibitors of CaOx crystallization processes.
From the above discussion it becomes apparent that
even though it is highly probable that urinary macromolecules play a major role in crystal nucleation, no
crystalline or macromolecular substrate has yet been
clearly identified as a promoter. Most of the urinary or
stone matrix macromolecules suggested or shown to be
crystallization promoters by some, have been characterized by others as inhibitors of, or to have no effect on,
crystallization. This leads to the following conclusions:
(1) the same urinary macromolecules may have dual effects on crystallization: they may inhibit crystal nucleation but promote crystal growth or vice versa; (2) their
inhibitory or promotional activity depends on the ambient conditions; (3) urinary macromolecules used in many
studies are not single entities, but mixtures of various
macromolecules which will influence crystallization differently under different in vitro experimental conditions;
and (4) promoters of nucleation are yet to be identified.
It appears that in the case of promoters of crystallization
in urine, all of the above may apply. Matrix substance
A, uromucoids, glycosaminoglycans (GAGs), and alcian
blue positive material (ABPM), are all complex entities.
Macromolecules belonging to GAGs and ABPM are a
heterogeneous group [100). There is a wide range in
degree of sulfation and charge density of the various
urinary GAGs: more highly sulfated GAGs appear to be
associated with stone formers' urines. Heparin, which
is not present in the urine but is one of the most highly
charged species of all GAGs, is shown to be a potent inhibitor of CaOx crystallization in vitro. Alcian blue precipitable material is shown to be inhibitory to crystallization and proposed to consist mainly of GAGs. But, it
must be pointed out that alcian blue is not a specific precipitant of GAGs but can also precipitate RNA-like material and other polyanions [100). RNA is a potent inhibitor of CaOx crystal aggregation in vitro [16, 100).

teries and in calcific disease of the aortic valve, electron
microscopic studies have established that extracellular
vesicles serve as the initial sites of apatite deposition
[64, 67, 69). The same is true of atherosclerotic plaque
formation [3]. Calcification of tumors is also associated
with membranes [105). Intracellular membrane vesicles
appeared to nucleate the apatite of psammoma bodies in
ovarian tumors and Michaelis-Gutmann bodies in malakoplakia [2], and when calcifying human meningiomas
were cultured in vitro, psammoma bodies arose in association with extracellular matrix vesicles [29). Extracellular vesicles derived from degenerating neoplastic
cells have also been shown to be involved in neoplastic
calcinosis [65). In tympanosclerosis of the middle ear
[75), matrix vesicles derived from fibroblastic cells were
the initial site of apatite deposition. Calcification during
apatitic osteoarthritis and calcifying tendinitis is also
shown to be mediated by matrix vesicles. During placental calcification, calcium hydroxyapatite precipitates
in association with extracellular membranous vesicles
[111). Calcification of bioprosthetic heart valves, fabricated from porcine aortic valves or bovine pericardium,
which is the main cause of their failure, is also membrane mediated [101). Initial nuclei of calcification are
associated with cellular membrane fragments derived
from pig cusp cells in the case of porcine valves and
from connective tissue cells in the case of bovine pericardium. Calcification of intrauterine devices also appears to be initiated by cellular membranous material
that is deposited on the devices during their exposure to
the uterine fluid [56). Dental plaque and calculus formation is yet another example of calcification initiated
by cellular membranes [3, 7, 9, 10, 106, 114). Membranes of microorganisms present in the dental plaque
nucleate calcium hydroxyapatite, and thus, initiate calculus formation.
One of the main reasons that cellular membranes act
as specific nucleators of calcium phosphate is proposed
to be the presence of lipids, and particularly, the acidic
phospholipids therein [7, 9, 10, 43, 44, 106, 114, 119,
120). Lipids have been demonstrated to be present, both
histochemically and biochemically, at physiological as
well as pathological calcification sites [9, 10, 11, 43, 44,
81, 119, 120). Although lipids account for a relatively
small proportion of the organic matrix of mineralized
tissues; 7-14% of bone, 2-6% of dentin, 12-22% of
newly mineralized enamel, approximately 9.6 % of submandibular salivary gland calculi, and 10.2 % of supragingival calculi, they have been isolated from matrices
of all types of such tissues [9, 10, 11, 43, 44, 81, 119,
120). In vitro, membranes, acidic phospholipids, lipid
extracts from various calcified tissues, and liposomes
have been shown to initiate calcium phosphate formation
from metastable solutions [25, 27, 82, 103, 104, 113).

Cellular Membranes and Calcific Diseases
Since the nature of macromolecules involved in heterogeneous nucleation of calcific crystals in urine is uncertain, studies from other pathological biomineralization
systems may provide direction. According to the current concepts, initial calcium phosphate deposition in a
number of calcific diseases [3, 7, 8, 9, 10, 11) occurs
on cellular membranes which are present at the calcification site, either as the limiting membrane of the socalled matrix vesicles or as cellular degradation products. For example, in medial sclerosis of the large ar600
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Based on a review of the literature on calcified tissues, it can be concluded that cellular membranes and
their lipids are intimately involved in both physiological
and pathological calcifications. Several lines of evidence
exist that point to a role for cellular membrane constituents in urolithiasis also. In a number of experimental
studies of metastatic calcification of kidneys [116], nonmitochondrial calcific deposits were either present in
proximal tubular basement membrane in association with
membranous outpouchings of the cell or in the apical
vacuoles of the epithelial cells. In a rat model, intranephronic calculosis caused by feeding purified diets is
membrane-mediated [17, 80, 83]. Vesicles derived from
the microvillous brush border of the proximal tubules
provide the nidus for intratubular deposition of calcium
phosphate. The deposits start in the lumens of segment
I of the proximal tubule and travel down the nephron
while at the same time accruing mass by laminar growth
in which both membranous vesicles and mineral are involved. Finally, these microliths become large enough
to be retained at the junction of the proximal tubule and
the loop of Henle. Mineral content of the microliths
increases, with the result that they become much more
compact and the laminated structure is finally lost. Experimentally induced intranephronic calculosis, resulting
from magnesium deficiency, also results in the formation
of microliths in the lumens of the proximal tubules [83]
and is shown to be initiated by deposition of mineral in
the apical vacuoles [ 17].
In the case of human urolithiasis, a number of renal
stones start at the tips of the renal papillae on plaques
called Randall's plaques [91, 92]. These plaques contain
cellular degradation products and crystals of calcium
phosphate. Stones formed on such plaques were once
thought to be rare, but a recent study of five hundred
spontaneously passed small stones collected in Spain by
Cifuentes-Delatte [19] has shown that 142 (28.4%) of
them contained nidi of necrotic material identifiable as
calcified tips of the renal papillae, indicating that at least
in these cases, the stones could have originated by
heterogeneous nucleation of crystals on the membranous
cellular degradation products.
The crystal membrane interaction discussed above
deals with the nucleation of calcium phosphate. Most
urinary stones however, contain calcium oxalate. Are
membranes and lipids involved in CaOx nucleation?
The answer to this question is yes. The involvement
may be direct or indirect. Indirectly, the membranes
and lipids may initiate nucleation of CaP which could
then act as a substrate for nucleation of CaOx. Membranes could also be directly involved in CaOx crystal
nucleation as suggested by experimental studies of CaOx
urolithiasis in the rat performed in my laboratory [50,
57, 58, 59] and by our in vitro studies that will be dis-

cussed later. Experimental studies of CaOx urolithiasis
induced in rats showed that irrespective of the method
utilized, the nature of the hyperoxaluria inducing agent
used, and the location of crystal formation within the
urinary system, CaOx crystals were always found associated with an eosinophilic, periodic acid-Schiff (PAS)
and colloidal iron positive material [50, 51]. In PAS
reaction, aldehyde groups created by periodic acid oxidation are demonstrated by Schiff reagent. Most glycoproteins stain positive with PAS while acid mucopolysaccahrides stain positive with acidified solution of
colloidal iron.
Even when a foreign body was implanted in the urinary bladder of hyperoxaluric rats, crystals did not nucleate on the native foreign body but on the organic material that coated the foreign body surface [52). Electron
microscopic examination of CaOx crystalline deposits in
male Sprague-Dawley rats identified the material associated with the crystals as cellular degradation products
consisting mostly of membranes [50, 59).

Cellular Membranes and Calcium Oxalate
Crystallization in vivo
Hyperoxaluria-associated crystallization
Intraperitoneal injection of sodium oxalate to male
Sprague-Dawley rats causes acute hyperoxaluria and almost instantaneous deposition of CaOx crystals in renal
tubules. Crystal deposition starts in the tubules of renal
cortex and eventually involves the renal medulla. Crystallization is associated with injury to the renal epithelium lining the tubules and is manifested by shedding of
brush border membrane into the urine. Crystals are almost always found associated with vesicular, membranous and fibrillar material [24, 50, 55, 59). Cytochemical staining suggests that calcium complexation with the
membrane starts the process of CaOx crystal formation.
Chronic administration of 0. 75 % ethylene glycol in
drinking water to male Sprague-Dawley rats for at least
two weeks results in renal deposition of CaOx crystals
[48). The deposition begins in the tubules of the renal
medulla, particularly those at the papillary tips. Renal
cortex may eventually become involved. Luminal crystals are invariably mixed with cellular degradation products (Fig. 1). Papillary tip stones contain cellular degradation products aggregating with the crystals (Fig. 2).

Membranuria in association with hyperoxaluria
The association between crystals and cellular degradation products described above could very well be a
phenomenon secondary to the precipitation of CaOx
crystals in the renal tubules. To improve our understanding of the role of membranes in crystallization of
CaOx and formation of kidney stones, we conducted a
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Figure 2 (on the facing page 605). Section through a
demineralized calcium oxalate monohydrate stone present at the renal papillary tip of a rat with nephrolithiasis. Cellular degradation products are closely associated
with the crystal ghosts (single arrows). Double arrows
mark the cellular degradation products located at a secondary nucleation site which is at the base of radially
organized ghosts of monoclinic CaOx monohydrate crystals. The stone was first examined by scanning electron
microscopy and then processed for transmission electron
microscopy.

administration of gentamicin sulphate or mercuric chloride, which affect the proximal tubular epithelial cells
and low doses of ethylene glycol can be used to induce
low grade hyperoxaluria to avoid heavy deposition of
crystals in the kidneys [38).
In one model, male Sprague-Dawley rats were given
daily subcutaneous injections of gentamicin sulphate, 100
mg/kg rat body weight and 0.25% ethylene glycol in
drinking water [38). One group of rats was given ethylene glycol only, another gentamicin sulphate only, and
the third group of rats received both simultaneously.
Rat urines were collected daily, and examined by light
microscopy with both bright field and polarized optics.
Urinary pH was measured. Urinary Ca2 +, Na+, K+,
Mg2 +, ammonium, phosphate, sulphate, citrate and oxalate were determined. Using these data, urinary CaOx
supersaturations were calculated. Kidneys and urinary
sediments were examined by light, scanning and transmission electron microscopy. With ethylene glycol only,
no morphological changes were found in the kidneys but
urinary oxalate levels were elevated. Gentamicin administration resulted in progressive renal tubular damage
and an increase in membranous cellular degradation
products in the urine. Neither ethylene glycol nor gentamicin alone induced CaOx crystals. However, simultaneous administration of the two resulted in CaOx crystalluria in all animals by day 4 without overt tubular
necrosis and crystal deposition in the kidneys. Crystals
were intimately associated with cellular degradation
products (Fig. 3). In addition, there was an increase in
both urinary calcium and oxalate concentrations, as well
as CaOx supersaturation, thereby, increasing the chance
of crystallization of CaOx. Supersaturation was, however, not high enough for the homogeneous nucleation
of crystals. In a separate study, a higher grade of
hyperoxaluria in association with gentamycin-induced
membranuria produced CaOx crystal deposition in kidneys of 63 % of the rats [71). We propose that membranous cellular degradation products acted as nucleators of
CaOx in this model.

Figure 1. Ghosts of CaOx monohydrate crystals (C)
present in the lumen of a renal papillary collecting duct
of a rat with nephrolithiasis. Ghosts are surrounded by
membranous vesicular cellular degradation products
(arrows).

----------------------------series of studies where low grade hyperoxaluria, inadequate to induce crystal deposition in the kidneys, was
induced in association with membranuria. Membrane
shedding was induced specifically from the proximal tubular brush border since brush border membrane is, in
many respects, similar to the membrane of matrix vesicles which are widely regarded as the initial site of both
physiological and pathological calcification [3, 9). Like
the membrane of matrix vesicles, renal brush border
membrane is rich in alkaline phosphatase activity, and
has high levels of phosphatidyl serine, sphingomyelin
and cholesterol [6]. Alkaline phosphatase is a polyfunctional enzyme and is closely associated with calcification
[121). Phosphatidyl serine is an acidic phospholipid
with strong affinity for calcium and has been postulated
to play a pivotal role in initiation of mineralization [8,
12, 120). Moreover, proximal tubular brush border is
one of the single largest membrane pool in mammalian
kidney [87), and proximal tubular epithelial cells are
highly susceptible to injury resulting in membrane
sloughing [112). Thus, the renal brush border membrane can provide a suitable surface for crystal nucleation in the urinary environment and is a prime candidate
as a crystal nucleator. Membranuria can be induced by
602
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Figure 4. Radially organized highly birefringent crystals of CaOx monohydrate formed in vitro in association
with vesicles of renal proximal tubular brush border
membrane.
Figure 3. Calcium oxalate dihydrate crystalluria particles in close association with non-crystalline material
(arrows). Transmission electron microscopy of such
deposits has revealed the crystals to be associated with
cellular degradation products [46).

all rats receiving the combined treatment had CaOx crystals in their urine. Crystals appeared to be associated
with membranous products.
Thus, in both the mercuric chloride/ethylene glycol
and gentamicin sulphate/ethylene glycol models, an increase in urinary oxalate or urinary CaOx relative supersaturation alone did not result in crystallization of CaOx.
Only when hyperoxaluria was associated with membrane
shedding did the crystals form. The membrane shedding
may be associated with other changes that so far we
have not studied and which may be involved in crystallization. But crystal formation in association with cellular
membranes does indicate some relationship between the
two and appears to implicate cellular membranes in
CaOx crystallization.

------------------------In a second in vivo rat model, membranuria was induced by administration of mercuric chloride which was
subcutaneously injected into male Sprague Dawley rats
at a dose of 0.5 mg per kg rat body weight per day. A
0.25% solution of ethylene glycol in drinking water was
given as the lithogen. Rats were housed in metabolic
cages. On days 1, 3, 5, and 7, their urines were examined by light and scanning electron microscopy. At the
end of the experiment, rats were sacrificed, and their
kidneys harvested and processed for light microscopic
examination using paraffin embedding and hematoxylin
and eosin (H&E) staining. Three other groups of control rats: one of normal rats receiving no additives, the
second with 0.25 % ethylene glycol administration, and
the third with 0.5 mg per kg rat body weight per day
mercuric chloride, were also studied along with the
experimental ones described above. Kidneys from all
groups of animals were free of crystals. All animals receiving mercuric chloride displayed membranuria as cellular degradation products in their urine. After 7 doses,

Cellular Membranes and Calcium
Oxalate Crystallization in vitro
Brush border membrane vesicles isolated from rat
kidneys, were incubated at a concentration of 0.1 mg
protein/ml in 0.2 µm filtered, metastable solutions of
CaOx at 37°C and initial pH of 6.5 for 24, 48, 72 or 96
hours [62]. The relative supersaturation of the solutions
was 6.33. After the incubations, solutions were filtered
through 0.2 µm Nucleopore filters and the precipitates
604
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Figure 5. Section through the center of a demineralized human calcium oxalate monohydrate stone after conventional
staining. The staining shows highly electron dense material (arrows) intimately associated with plate-like ghosts of
monoclinic CaOx crystals.
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Figure 6. Malachite green staining of demineralized
calcium oxalate monohydrate stone with (a) and without
(b) chloroform methanol treatment. The treatment reduced the intensity of staining of the matrix material
indicating a loss of lipidic constituents.

-------------------------------------were examined by scanning electron microscopy to identify the crystals. Depletion of calcium and oxalate in the
filtrate was determined by atomic absorption spectrophotometry and scintillation counting. There was a gradual
increase in the depletion of calcium and oxalate from the
metastable solution with a concomitant decrease in CaOx
relative supersaturation. By 72 hours, there was a
49. 8 % decrease in calcium, 43 .6 % in oxalate and 60.4 %
in CaOx relative supersaturation and crystals of CaOx
were seen associated with the substrate. Drops from
some of the solutions were examined for birefringence
by polarizing optics of a light microscope. Aggregates
of highly birefringent crystals of CaOx were seen in
close contact with the membrane vesicles (Fig. 4).
There was no change in the calcium or oxalate level of
the metastable solution of CaOx incubated without the
membrane substrate. We concluded that brush border
membranes can induce CaOx crystallization from a
metastable solution which would otherwise not undergo
spontaneous crystal nucleation.
In constant composition crystallization experiments,
calcium and oxalate consumption started much earlier
when brush border membranes were present in the solution, occurring within 258, 32, or 8 minutes of incubation in a metastable calcium oxalate solution at relative

Figure 7. Chloroform methanol treatment of the demineralized stone disclosed membranous material in the
electron dense material associated with the crystals.

------------------------------------supersaturations of 6, 10 or 12 respectively [63]. The
plate-like crystals were formed in association with the
membrane vesicles. Since crystallization started within
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Figure 8. Membranous profiles (arrows) were seen
tightly bound to the surface of calcium oxalate crystal
ghosts after conventional fixation and staining. Inset
shows the profile of a vesicle.

8 minutes of the incubation of brush border membrane
in a CaOx solution of a low relative supersaturation of
12, there is a distinct possibility that membrane associated crystallization of CaOx might occur in the urine
of stone formers which is known to have a CaOx relative supersaturation much higher than 12.
The effect of CaOx urinary stone matrix and its
lipid contents on in vitro crystallization of CaOx was
also studied [60]. Incubation of whole matrix or its
lipids in a metastable solution of CaOx resulted in the
depletion of calcium and oxalate, a decrease in the CaOx
relative supersaturation and the formation of CaOx crystals. No calcium or oxalate depletion, or CaOx crystallization was detected in the metastable solution without
the substrates.

urinary stones. Cytochemical examination of decalcified
human CaOx urinary stones has shown osmiophilic, and
PAS and colloidal iron positive material in their matrices
indicating the presence of cellular degradation products
[51, 61] . Boyce [14, 15] also found osmiophilic material in urinary stones but interpreted it as glycoprotein.
Kim [68] interpreted the osmiophilia of CaOx dihydrate
as having been caused by lipids associated with the crystals. Transmission electron microscopy of demineralized
CaOx stones revealed the presence of cellular degradation products in the intercrystalline spaces [51, 52, 55,
66]. Furthermore, the presence of lipids in stone matrix
was confirmed when lipids were isolated from stone
matrix by biochemical extraction and identified using
thin layer and column chromatographic techniques [61].
All urinary stones, including those composed of CaOx,

Cellular Membranes and Lipids in
Urine and Urinary Stones
If membranes play a role in crystal nucleation during urolithiasis then one should be able to find membranous profiles and their constituent lipids in urine and
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10
Figure 9. Section through demineralized, partially demineralized and intact calcium oxalate crystals. Staining
of intact crystals is denser than that of the demineralized
crystals.

Figure 10. Section through demineralized calcium oxalate crystals induced in whole human urine by adding sodium oxalate. Cellular degradation products are present
in the intercrystalline areas.

---------------------------

-------------------

Localization of lipids in matrices of calcium oxalate
stones
To better understand the role of lipids and membranes in stone formation, we cytochemically localized
lipids in stones. Because most lipids are easily lost during processing for electron microscopy, a newly developed technique using malachite green (MG) during fixation was utilized [35]. Fragments of urinary stones
comprising mainly of CaOx monohydrate were demineralized by treatment with a mixture of Kamovsky's fixative and 0.25 M ethylenediaminetetraacetic acid (EDTA)
[53, 54] . Following demineralization, the specimens
were stained with 0.1 % MG in 2 % glutaraldehyde and
postfixed in 1 % osmium tetroxide. Control specimens
were fixed without MG. The specimens were then dehydrated, embedded in Spurr's plastic, sectioned and
examined using a Zeiss 10 transmission electron microscope. In addition, a few specimens were first treated
with chloroform methanol and then stained with MG.
Demineralization resulted in the disappearance of
crystals and the formation of crystal ghosts (Fig. 5).
Both control and MG stained stone sections demonstrated the presence of electron dense osmiophilic material in close contact with the crystal ghosts. But MG

struvite and uric acid contain some lipids. But calcific
urinary stones, e.g., calcium oxalate and struvite stones,
contain more phospholipids than the uric acid stones
[61] . A number of phospholipids, including phosphatidyl ethanolamine, phosphatidyl choline, sphingomyelin, phosphatidyl serine, phosphatidyl glycerol and
cardiolipin have been identified in stone matrices.
Neutral and glycolipids have also been isolated and analyzed from a number of CaOx urinary stones and identified; these include mono-, di-, and triglycerides, sterol
ester and cholesterol and free fatty acids as neutral lipids
and sulfatides, galactosyl-di-glycerides, I, II galactocerebroside and glucocerebroside as glycolipids. Thus,
with respect to the presence of lipids, urinary stone matrix is not different from the matrix of a number of biomineralized substances such as bone, dentine, enamel,
and various types of salivary calculi.
Epithelial cells are continuously sloughed and excreted by both normal human males and females, 78,000
cells/hour by males and 68,000 cells/hour by females,
supplying cellular membranes to the urine [89]. Biochemical analysis discloses that urine from stone formers
contain more and different phospholipids than the urine
from normal humans [122] .
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stained sections (Fig. 6a) showed much more intense
staining which disappeared after chloroform methanol
treatment (Fig. 6b), indicating its lipidic nature.
Chloroform methanol treatment also revealed the presence of membranous profiles in the electron dense material associated with the crystals (Fig. 7).
Profiles of membranous vesicles were seen tightly
bound to the surfaces of crystal ghosts (Fig. 8). Sections through partially demineralized crystals showed
that staining of intact crystals was much more dense than
that of the demineralized crystals (Fig. 9). It is well
known that demineraliz.ation is necessary for total extraction of phospholipids from mineralized tissues [9]. Prior
demineraliz.ation was also shown to increase the yield of
phospholipids from calcific urinary stones [61].

problems associated with using excreted urine. First,
human urine used in crystalliz.ation studies is actually
bladder urine which is different from the urine present
in kidney tubules where kidney stones form [26]. It is
well established that urine produced at the glomerulus
undergoes several changes when it passes through various segments of the renal tubules. Along with many
ions, water is reabsorbed changing the ionic concentration of the urine with obvious impact on relative supersaturation of various stone forming salts. Macromolecules like Tamm-Horsfall protein, nephrocalcin and osteopontin are secreted and added to the urine, again with
obvious repercussions for crystalliz.ation. In addition,
many more macromolecules may be added when the
urine reaches the bladder [26]. Thus, urinary environment in the earlier segments of the renal tubules is very
different from the one in later segments and different
still from the bladder urine. Crystals that initiate stone
formation may form as early as the loop of Henle [21].
Secondly, urine goes through many processing steps,
such as filtration, centrifugation, ultrafiltration, dilution
and lyophiliz.ation before being utilized for the studies.
Depending on such factors as: the pore size of the filter
paper, speed and length of centrifugation, and molecular
weight cut off during ultrafiltration, membranous cellular degradation products as well as many normally and
abnormally occurring macromolecules will be lost during
the processing. This will certainly influence crystalliz.ation. Consequently, the study of crystal nucleation in
excreted bladder urine may not be entirely relevant to
what happens during kidney stone formation in vivo.
Still, the studies performed in vitro in inorganic solutions or urine, provide some insight into crystalliz.ation
processes, but results must be interpreted judiciously and
supported by studies in vivo in animal models.
Many of the normally occurring, well characterized
urinary macromolecules such as: osteopontin, nephrocalcin, prothrombin fragment 1, urinary bikunin (uronic
acid rich protein), and Tamm-Horsfall protein are currently considered inhibitors of CaOx crystalliz.ation. It
is possible that some of these, once adsorbed on an existing surface, such as a growing stone, may promote
further crystalliz.ation and stone growth.
CaP has been considered a nucleator because it is
present in almost all urinary stones, it is common in
urine, and can promote nucleation of CaOx in vitro.
Recent studies have indicated that urinary CaP supersaturation in the loop of Henle is high enough to support
nucleation of calcium phosphate crystals. These CaP
crystals can then nucleate CaOx crystals when they
reach the collecting ducts where urine is supersaturated
with respect to CaOx. In the animal model, however,
CaOx crystals did not deposit on the surfaces of CaP
crystals.

Crystal induction in human urine
Calcium oxalate crystals were induced in whole
human urine by adding sodium oxalate at 37°C in a
shaker water bath as described earlier [110]. After 3
hours of incubation, crystals were harvested by centrifugation at 10,000 g for 30 minutes. Crystals were identified by X-ray diffraction and scanning electron
microscopy. They were washed with distilled water,
demineralized, and processed for transmission electron
microscopy [54, 55]. Lipids were extracted and isolated
from the crystals using chloroform methanol and identified using thin layer chromatographic techniques [61].
Crystals were mostly that of CaOx monohydrate and
demineraliz.ation resulted in the generation of crystals
ghosts (Fig. 10). Cellular degradation products were
found closely affiliated with the crystal ghosts. A
variety of lipids including phospholipids, glycolipids,
and neutral lipids were identified in crystal matrices
(Khan et al., submitted for publication).

Concluding Remarks
It is now generally acknowledged that crystal nucleation in the urine is heterogeneous. What is still debated
is the nature of the nucleating substrate or substrates.
Since many substances found in urine have been shown
to be capable of nucleating calcific crystals in vitro, possibility exists for the presence of more than one type of
nucleators in the urine. Nucleating potential of the substrate is most probably influenced by the urinary conditions. Most crystalliz.ation studies in vitro are carried
out in inorganic solutions or urine. One should, however, be careful about extrapolating results of in vitro
studies in inorganic solutions to in vivo conditions in the
kidneys. The physiological, hydrodynamic and physicochemical environment of the kidney cannot be reproduced. Even the studies carried out in human urine may
result in erroneous interpretations. There are many
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Evidence has been provided here that: (1) membranous cellular degradation products are always present in
urine and urinary stones; (2) in experimental animal
models, renal crystal deposits are invariably associated
with membranous cellular degradation products; and (3)
cellular membranes can induce nucleation of CaOx crystals from a metastable solution in vitro and the metastable urine in vivo. In addition, while CaP and other crystals must themselves be formed before they can act as a
substrate for CaOx crystallization, membranous vesicles
are ubiquitous in urine as a natural byproduct of renal
epithelial cell turnover.
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A. Boskey: Which do you think comes first in vivo membrane degeneration leading to crystal nucleation or
the presence of crystals to cell breakdown. Is there
proof for or against your answer?
Author: Recent studies by our group as well as others
have provided evidence that oxalate ions themselves are
injurious to the cell membranes. There was increased
excretion of many renal membrane-associated enzymes
by hyperoxaluric rats [126]. In tissue culture experiments [124], MDCK (Madin-Darby canine kidney) cells
exposed to low concentrations of oxalate demonstrated
a loss of cell to cell contact, decreased cell viability, and
adherence to the substrate. There was an increase in adenine release as well as many membrane-associated enzymes into the culture medium. Exposure of LLC-PKl
cells, another renal epithelial cell line, to oxalate also
resulted in cell injury [130]. Thus, hyperoxaluria that
generally precedes CaOx nephrolithiasis can by itself
induce degenerative changes in the membranes of the
epithelial cells lining renal tubules.

Discussion with Reviewers

G.H. Nancollas: The micrographs certainly show some
interesting juxtapositioning of phases, but it will be
important to know whether the author was able to confirm the inorganic and organic phases either by energy
dispersive X-ray microanalysis (EDX) or through the
TEM, by electron diffraction for the mineral phases.
This would make the argument concerning the nucleation
of crystallites at the surfaces of cellular degradation
products much more compelling. The characterization
of crystal ghosts following demineralization will be of
particular interest.
Author: Both crystalline and organic phases were analyzed by EDX. An analysis of demineralized CaOx
crystals and their associated matrix by EDX disclosed
the absence of both calcium and phosphorus. As is generally known, and I have pointed out in this paper and
others, CaP phase is often seen in association with CaOx
crystalline deposits. But many of the stone fragments
chosen for this study did not contain CaP crystals and
the matrix material associated with CaOx crystals was
negative for calcium and phosphorus, both before and
after demineralization. Transmission electron microscopy of demineralized stones also did not reveal CaP

A. Boskey: Do you not think that Selye's calciphylaxis
model is another illustration of membrane associated
calcification?
Author: Calcium phosphate crystal formation during
calciphylaxis may very well be membrane associated.
A. Boskey: How much of a contribution does calcium
and lysosomal enzyme release from dying cells contribute to the lipid induced calcification?
Author: In the case of CaOx nephrolithiasis, urinary
oxalate plays a more important role than urinary calcium. Urine from both normal humans and rats is inhibitory to growth of CaOx crystals. However, in an experimental study, urine from rats with renal cellular injury
was significantly less inhibitory to CaOx crystal growth
[123].
W. Achilles: How would you explain your findings that
male rats are prone to form CaOx while females tend to
form CaP stones? Was there a significant difference in
urine composition of both sexes?
Author: There were no significant differences in uri614
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formers renal epithelial cells are organized differently so
head groups involved in crystal nucleation and binding
are properly oriented for these activities. We found that
urine of stone formers have more acidic phospholipids
than the urine of non stone formers (unpublished).
Here a distinction should be made between crystal
formation and stone formation. Under normal conditions, crystals nucleate and stay separate, easily passing
through the nephron and excreted with the urine. In a
pathological situation, on the other hand, there may be
more lipids and membranes or membranes with properly
aligned lipids that may bridge crystals together and promote crystal aggregation and their retention within the
kidneys.

nary chemistries of male and female rats. Interestingly
enough, male hyperoxaluric rats produced aggregated
CaOx crystals while female rats produced single crystals. Since aggregated crystals have a better likelihood
of retention within the nephron, it is possible that there
are differences in urinary crystal aggregation inhibitors
between males and females.
Sex hormones may also be involved. Lee et al.
[127] assessed the role of testosterone in CaOx nephrolithiasis. 0.5 % ethylene glycol was administered in
drinking water to male and female, intact and castrated
Sprague-Dawley rats. All rats became hyperoxaluric.
All 7 intact male rats had CaOx crystal deposits in their
kidneys and five of them produced stones. Only 2 of 7
castrated males had CaOx crystal deposits in their kidneys and only one of them produced a stone. None of
the female rats, intact or castrated, produced CaOx stone
and only 2 of 7 in each group had small amounts of
CaOx crystals in their kidneys.

W. Achilles: Are the phospholipids found in urine constituents of kidney CDP or do they come from blood by
glomerular filtration?
Author: Urinary phospholipids excreted by kidneys
with normal glomerular function are, most probably, of
renal cellular origin.

W. Achilles: The term cellular degradation products
(CDP) comprises a great variety of chemically and physically different compounds. Can you specify which class
of substrates or moieties are most likely to act as crystal
nucleators?
Author: According to the current concepts, it is the
phospholipids of cellular membranes that are involved in
nucleation of calcific crystals.

R. Ryall: The author describes studies demonstrating
that lipids can induce precipitation of CaOx from inorganic solutions in vitro. These will not reflect events
occurring in urine and may not be relevant in vivo. Is
there any evidence that lipids can induce CaOx crystallization in human urine?
Author: Actually, I have discussed results of both in
vitro and in vivo studies and have demonstrated that
membranes and lipids promote CaOx crystallization in
both inorganic solutions and urine. As I discussed in the
paper, CaOx crystals were induced in vitro in inorganic
solutions of low CaOx supersaturation by incubating
brush border membrane vesicles derived from renal
proximal tubular epithelium. CaOx crystals were also
induced in vivo in the urine of hyperoxaluric rats by
experimental induction of membranuria. I have not performed any in vitro studies using human urine. This
matter has been discussed in detail in Concluding
Remarks.

W. Achilles: Is there any evidence for potential role of
CDP in crystal aggregation also, or do you think that
CDP are only of importance in nucleating crystals?
Author: According to Mandel [129] and Lieske et al.
[ 128] cellular membranes of injured renal epithelial cells
can bind CaOx crystals. Transmission electron microscopic studies of CaOx ministones produced by hyperoxaluric rats showed that crystals aggregated together by
entrapment within a meshwork of membranous cellular
degradation products [53] . Another study showed crystal retention within an injured rat urinary bladder by being trapped in a mass of cellular degradation products
[126]. Thus, CDP can bind the crystals and help in
their aggregation and retention within the kidneys.

R. Ryall: When does a urinary macromolecule become
a "cellular degradation product", rather than a normal
filtered or secreted component of urine?
Author: It is a cellular degradation product when associated with injured, dying or dead cells. Cellular degradation products occur normally in the urine since older
cells of the renal epithelium are continuously being replaced by new ones. Of course, membranous material
will not be a filtered component of the urine. Obviously, membranous substrates which can possibly nucleate
calcific crystals are abundant in the urine. Perhaps, it
is why the urine contains so many inhibitors of crystalli-

W. Achilles: If CDP were causative in stone formation,
stone formers should have a higher rate of tubular cell
destruction and more cellular debris in their urine. Can
you confirm this?
Author: I really do not have a good answer. Nobody
to my knowledge has looked into this. It may not be
necessary to have more CDP's in stone formers urine.
They may just have more of those lipids, like many
phospholipids, that are involved in crystallization. Or,
perhaps, the lipids of cellular membranes in kidney stone
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zation; an evolutionary response to the abundance of
promoters therein.

R. Ryall: How do you know that the crystal associated
substances are cellular degradation products?
Author: By microscopic examination of H&E stained
light microscopic slides and transmission electron
microscopy. This does not, however, mean that there
were no normally occurring substances associated with
the crystals.

R. Ryall: Does malachite green bind to CaOx crystals?
Author: I do not know whether inorganic CaOx crystals bind the dye. However, CaOx crystals present in
the urine and urinary stones are always coated with an
organic substance, and thus, inorganic surface may not
be available for binding.
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